Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
Links relacionados
- Similares em SciELO
Compartilhar
Boletim de Pneumologia Sanitária
versão impressa ISSN 0103-460X
Bol. Pneumol. Sanit. v.10 n.2 Rio de Janeiro dez. 2002
2- RESUMOS DOS TRABALHOS APRESENTADOS NO 33º WORLD
CONFERENCE ON LUNJ HEALTH - MONTREAL/CANADÁ - 2002
MDR-TB: resistence to INH Associated with RMP, and only to RMP
Natal S*; Toledo A; Penna MLF; Valente J
CRPHF/FNS/MS & IMS/UERJ. Rio de Janeiro. Brazil
Resistance is a major problem within our milieu. Drugs should be handled by people with adequate knowledge of both the pharmacology of the drugs used in the treatment of tuberculosis and its etiopathogeny.
Discontinuance of treatment remains the great "villain" for the poor performance of the TCP.
Patients with a Tb treatment history, even if last discharged for "cure", should be adequately monitored for resistance detection.
Special care should be given to patients with Tb- HIV co-infection.
Tuberculosis is no simple task, as one believed in the early 80s, it is still the disease that kills more adults in productive age, and annually it can kill more than AIDS.
It is important that people involved with "tuberculosis", at all levels, keep in mind that the guidelines are important as a TCP strategy, but that every patient is an individual with his/her own particularities.
*E-mail:sonianatal@uol.com.br